HPS-4/TIMI 65/ORION-4: A double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People with Atherosclerotic Cardiovascular Disease

Grant

Date/time Interval

  • March 27, 2019 - March 26, 2023
  • Total Award Amount

  • 110000.00
  • Direct Costs

  • 80882.00
  • Sponsor Award Id

  • Contributor

  • Bittner, Vera   Principal Investigator  
  • Jackson, Elizabeth   Investigator  
  • Kim, Joonseok   Investigator